Thymic Cancer
Reports from Tel-Aviv University advance knowledge in thymic cancer
Published in Drug Week, November 2nd, 2007
"' To determine whether the use of adjuvant radiation in the treatment of invasive thymic tumors affects survival and to identify prognostic factors. The files of 47 patients with thymic tumors treated by adjuvant radiation in our institute from 1984 to 2003 were reviewed for data on prognosis and survival," scientists writing in the American Journal of Clinical Oncology - Cancer Clinical Trials report.
"All patients underwent thoracotomy followed by either total macroscopic resection (n = 42) or biopsy (n = 5). The radiation dose ranged from 26 to 60 Gy. Median duration of follow-up was 10.6 years. Overall 5-year survival was 73% (60%-88%): 77% for thymoma (n =...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-11-02)
More Articles from Drug Week
- Addiction Medicine
Tolerance to inhalants may be caused by changes in gene expression - Allergies
Asthma symptoms reduced by interleukin inhibition treatment pitrakinra - Arthritis
What's been causing your knee to ache? Smurfs! - Asthma
Funding Source May Be Associated With Findings Regarding Adverse Effects in Corticosteroid Studies - Biomedicine
LIALDA (TM) demonstrates prolonged release of mesalamine - Biomedicine
New study: pine bark extract boosts nitric oxide production - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
